A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency

This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germany, Italy, and United Kingdom

Inclusion Criteria:

• Patients with Growth Hormone Deficiency
• Patients treated with NutropinAq®
• Patients having completed growth (fused epiphyses)

Exclusion Criteria:

• Active neoplasia
• Pregnancy